dMY Technology in its latest said it closed an $8 million private placement in tandem with its IPO completed last week. The tech-focused SPAC trades on the NYSE under “DMYI.U”. Read more.
Related Posts
CM Life Sciences II Files for $200M IPO
Focusing on the life sciences sector for a potential acquisition, the SPAC is led by CEO Eli Casdin, founder of Casdin Capital, an investment firm focused on the life sciences and healthcare industry.
North Atlantic Acquisition Seeks 6-Month Extension
The SPAC a month ago was warning it might liquidate, but has decided to forge onward in pursuit of a deal.
World Quantum Growth Cuts Deal Size by 33% Ahead of $200M IPO
The new SPAC is targeting the FinTech sector in the U.S. and EMEA.
Aimfinity Investment I Files for $70M IPO
The tech-focused SPAC will not consider any business operating in China, Hong Kong or Macau, according to the filing.